-
Start Preamble
Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 22, 2009, 8 a.m.to July 23, 2009, 5 p.m., Marriott Bethesda North Hotel & Conference Center, Bethesda, MD which was published in the Federal Register on June 11, 2009, 74FR27806.
This notice is amended to change the title from “NCI-ARRA Competitive Revisions-Pre Clinical, Drug Discovery & Imaging” to “NCI-ARRA Competitive Revisions & Grand Opportunity-Pre Clinical, Drug Discovery & Imaging”. The meeting is closed to the public.
Start SignatureDated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16894 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 07/16/2009
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- E9-16894
- Pages:
- 34583-34583 (1 pages)
- PDF File:
- e9-16894.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute